Sixth Anniversary: Full-Service Internet Securities Firm Takes Initial Shape Internet Securities Firm Takes Initial Shape Internet Securities Firm Takes Initial Shape

November 05, 2025

info.png

On June 12, Beijing time, Burning Rock Biotech was listed on NASDAQ. This leader in the oncology gene testing track has received much attention since the news of its listing was announced. Investor enthusiasm was reflected in the secondary market, with the company's stock opening at $22.8, up 38% from the offering price of $16.5, and then quickly rising to a high of $26.37 during trading, closing up 49.27% at $24.63, with a market value exceeding $2.5 billion. It is reported that Tiger Brokers served as an underwriter for Burning Rock Biotech, successfully helping it obtain orders exceeding $360 million, of which retail subscriptions exceeded 10,000 people with subscription amounts reaching $223 million, once again breaking Tiger Brokers' platform record for US stock IPO retail subscriptions, demonstrating Tiger Brokers' unique value as an emerging technology investment bank and strong business synergy capabilities.

"As entrepreneurs, we can better understand and relate to Chinese startups, empathize with their pain points in going public, and provide customized services. In addition, our senior US investment banking team, with deep understanding of the US market environment and industry, can provide more targeted professional advice on finance, valuation and other aspects for these companies. Being a listener and long-term strategic partner for Chinese concept companies, growing together with them, this is what Tiger wants to do." said the head of Tiger Brokers' investment banking department. On June 12, Beijing time, Burning Rock Biotech was listed on NASDAQ. This leader in the oncology gene testing track has received much attention since the news of its listing was announced. Investor enthusiasm was reflected in the secondary market, with the company's stock opening at $22.8, up 38% from the offering price of $16.5, and then quickly rising to a high of $26.37 during trading, closing up 49.27% at $24.63, with a market value exceeding $2.5 billion. It is reported that Tiger Brokers served as an underwriter for Burning Rock Biotech, successfully helping it obtain orders exceeding $360 million, of which retail subscriptions exceeded 10,000 people with subscription amounts reaching $223 million, once again breaking Tiger Brokers' platform record for US stock IPO retail subscriptions, demonstrating Tiger Brokers' unique value as an emerging technology investment bank and strong business synergy capabilities. "As entrepreneurs, we can better understand and relate to Chinese startups, empathize with their pain points in going public, and provide customized services. In addition, our senior US investment banking team, with deep understanding of the US market environment and industry, can provide more targeted professional advice on finance, valuation and other aspects for these companies. Being a listener and long-term strategic partner for Chinese concept companies, growing together with them, this is what Tiger wants to do." said the head of Tiger Brokers' investment banking department. On June 12, Beijing time, Burning Rock Biotech was listed on NASDAQ. This leader in the oncology gene testing track has received much attention since the news of its listing was announced. Investor enthusiasm was reflected in the secondary market, with the company's stock opening at $22.8, up 38% from the offering price of $16.5, and then quickly rising to a high of $26.37 during trading, closing up 49.27% at $24.63, with a market value exceeding $2.5 billion. It is reported that Tiger Brokers served as an underwriter for Burning Rock Biotech, successfully helping it obtain orders exceeding $360 million, of which retail subscriptions exceeded 10,000 people with subscription amounts reaching $223 million, once again breaking Tiger Brokers' platform record for US stock IPO retail subscriptions, demonstrating Tiger Brokers' unique value as an emerging technology investment bank and strong business synergy capabilities.